Orit Lache

1.2k total citations
15 papers, 955 citations indexed

About

Orit Lache is a scholar working on Cell Biology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Orit Lache has authored 15 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 7 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Orit Lache's work include Hemoglobin structure and function (9 papers), Neonatal Health and Biochemistry (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Orit Lache is often cited by papers focused on Hemoglobin structure and function (9 papers), Neonatal Health and Biochemistry (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Orit Lache collaborates with scholars based in Israel, United States and Canada. Orit Lache's co-authors include Andrew P. Levy, Nina S. Levy, Benjamin Enav, Rebecca M. Ricklis, Meira Melamed‐Frank, Rabea Asleh, Rachel Miller‐Lotan, Flavio Lejbkowicz, Ofer Binah and Naim Shehadeh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of the American College of Cardiology.

In The Last Decade

Orit Lache

14 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orit Lache Israel 11 530 318 238 235 168 15 955
Thomas Ardito United States 23 288 0.5× 1.1k 3.3× 318 1.3× 151 0.6× 256 1.5× 38 1.8k
Moriko Ito United States 15 153 0.3× 667 2.1× 258 1.1× 99 0.4× 102 0.6× 16 1.2k
Jens Hirchenhain Germany 13 354 0.7× 909 2.9× 286 1.2× 93 0.4× 77 0.5× 25 1.6k
R. Brian Doctor United States 26 246 0.5× 832 2.6× 142 0.6× 92 0.4× 314 1.9× 44 1.6k
Tobias Hermle Germany 16 129 0.2× 514 1.6× 697 2.9× 264 1.1× 55 0.3× 30 1.2k
Andreas Gocht Germany 18 124 0.2× 556 1.7× 77 0.3× 55 0.2× 251 1.5× 47 1.4k
Joshua Lehrer‐Graiwer United States 10 122 0.2× 707 2.2× 290 1.2× 96 0.4× 53 0.3× 18 1.4k
Jason C. Cheung United States 8 169 0.3× 401 1.3× 172 0.7× 45 0.2× 345 2.1× 10 1.1k
Anand Patel United States 17 97 0.2× 535 1.7× 139 0.6× 54 0.2× 114 0.7× 19 904
Mary O. Carayannopoulos United States 15 81 0.2× 727 2.3× 151 0.6× 190 0.8× 262 1.6× 32 1.4k

Countries citing papers authored by Orit Lache

Since Specialization
Citations

This map shows the geographic impact of Orit Lache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Lache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Lache more than expected).

Fields of papers citing papers by Orit Lache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Lache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Lache. The network helps show where Orit Lache may publish in the future.

Co-authorship network of co-authors of Orit Lache

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Lache. A scholar is included among the top collaborators of Orit Lache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Lache. Orit Lache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Andreou, Pantelis, Andrew P. Levy, John L. Sapp, et al.. (2023). Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study. Journal of the American Heart Association. 12(19). e030288–e030288. 3 indexed citations
2.
Levy, Nina S., et al.. (2023). Molecular Insights into IQSEC2 Disease. International Journal of Molecular Sciences. 24(5). 4984–4984. 9 indexed citations
3.
Cahill, Leah E., Andrew P. Levy, Henry N. Ginsberg, et al.. (2023). The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants. Diabetes Care. 46(11). 1941–1948. 4 indexed citations
4.
Levy, Andrew P., Henry N. Ginsberg, Steven G. Coca, et al.. (2020). Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes. Journal of the American College of Cardiology. 75(5). 512–521. 29 indexed citations
5.
Levy, Nina S., et al.. (2019). IQSEC2-Associated Intellectual Disability and Autism. International Journal of Molecular Sciences. 20(12). 3038–3038. 26 indexed citations
6.
Adir, Yochai, et al.. (2019). COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.. PubMed. 21(1). 19–23.
7.
Beeri, Michal Schnaider, Hung‐Mo Lin, Mary Sano, et al.. (2018). Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes. JAMA Network Open. 1(7). e184458–e184458. 17 indexed citations
8.
Levy, Nina S., Moshe Vardi, Shany Blum, et al.. (2013). An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype. Clinical Chemistry and Laboratory Medicine (CCLM). 51(8). 1615–1622. 28 indexed citations
9.
Simpson, Melissa, Janet K. Snell‐Bergeon, Gregory L. Kinney, et al.. (2011). Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes. Cardiovascular Diabetology. 10(1). 99–99. 36 indexed citations
10.
Levy, Andrew P., Rabea Asleh, Shany Blum, et al.. (2009). Haptoglobin: Basic and Clinical Aspects. Antioxidants and Redox Signaling. 12(2). 293–304. 222 indexed citations
11.
Avivi, Aaron, Imad Shams, Alma Joel, et al.. (2005). Increased blood vessel density provides the mole rat physiological tolerance to its hypoxic subterranean habitat. The FASEB Journal. 19(10). 1314–1316. 60 indexed citations
12.
Roguin, Ariel, Samy Nitecki, Irit Rubinstein, et al.. (2003). Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovascular Diabetology. 2(1). 18–18. 20 indexed citations
13.
Roguin, Ariel, Aaron Avivi, Samy Nitecki, et al.. (2003). Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole ratSpalax ehrenbergiVEGF. Proceedings of the National Academy of Sciences. 100(8). 4644–4648. 11 indexed citations
14.
Asleh, Rabea, Mark Shilkrut, Ofer Binah, et al.. (2003). Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease. Circulation Research. 92(11). 1193–1200. 213 indexed citations
15.
Melamed‐Frank, Meira, Orit Lache, Benjamin Enav, et al.. (2001). Structure-function analysis of the antioxidant properties of haptoglobin. Blood. 98(13). 3693–3698. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026